Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ESSA PharmaTrevenaCatalyst BiosciencesASLAN PHARMACEU/ADRVERONA PHARMA P/S
SymbolNASDAQ:EPIXNASDAQ:TRVNNASDAQ:CBIONASDAQ:ASLNNASDAQ:VRNA
Price Information
Current Price$5.41$0.77$6.83$2.10$6.70
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$8.00$3.50$25.00$6.50$37.00
% Upside from Price Target47.87% upside354.55% upside266.03% upside209.52% upside452.24% upside
Trade Information
Market Cap$114.19 million$70.23 million$78.51 million$68.59 million$89.53 million
Beta2.012.612.283.09-0.77
Average Volume38,308641,559361,693227,292105,516
Sales & Book Value
Annual RevenueN/A$5.73 million$10,000.00N/AN/A
Price / SalesN/A12.448,223.32N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.37 per share$0.50 per share$10.04 per share$0.96 per share$6.40 per share
Price / BookN/A1.540.68N/AN/A
Profitability
Net Income$-10,440,000.00$-30,780,000.00$-30,060,000.00$-42,190,000.00$-26,560,000.00
EPS($1.46)($0.42)($2.68)($1.40)($2.02)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-68.43%-64.05%-52.45%-129.37%-50.99%
Return on Assets (ROA)-51.20%-40.52%-48.87%-66.68%-42.33%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.23%0.02%1.12%0.02%
Current Ratio9.74%3.31%9.82%1.88%4.07%
Quick Ratio9.74%3.31%9.82%N/A4.07%
Ownership Information
Institutional Ownership Percentage59.08%20.36%56.51%5.96%56.28%
Insider Ownership PercentageN/A3.40%4.59%N/AN/A
Miscellaneous
Employees152921N/A22
Shares Outstanding20.76 million92.59 million12.04 million32.05 million13.17 million
Next Earnings Date5/8/2020 (Estimated)3/11/2020 (Estimated)3/5/2020 (Estimated)3/27/2020 (Estimated)2/25/2020 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel